Population-based Cohort of Endometrial Cancer Survivors in Utah
Population-based Cohort of Endometrial Cancer Survivors in Utah
批准号:
8814097
负责人:
MIA HASHIBE
金额:
$19.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-12 至 2017-07-31
关键词:
AddressAgeAreaBehaviorBirth CertificatesBody Weight decreasedCancer PatientCancer SurvivorCancer SurvivorshipCardiotoxicityCardiovascular DiseasesCessation of lifeCharacteristicsChronicCognitive deficitsColorectal CancerComorbidityComputerized Medical RecordDataData LinkagesDatabasesDiagnosisDiseaseDistressEducational workshopEndometrial CarcinomaEpidemiologic StudiesExerciseFamilyFatigueFemaleFoundationsFutureHealthHealthcareHealthcare SystemsHospitalsIncidenceIndividualInterventionLate EffectsLicensingLinkLong-Term EffectsMalignant Childhood NeoplasmMalignant NeoplasmsMalignant neoplasm of prostateMalignant neoplasm of testisMedical RecordsMedicareModalityNational Cancer InstituteOsteoporosisPatient Self-ReportPatientsPilot ProjectsPopulationPopulation DatabaseQuestionnairesRadiation therapyRecording of previous eventsRecordsRegistriesRelative RisksReportingResearchResearch DesignResearch InfrastructureResearch PriorityResourcesRiskSamplingScandinavianSecond Primary CancersSexual Dysfunction and InfertilitySourceSurvival RateSurvivorsTimeToxic effectUnited StatesUtahVotingWomanWorkbasecancer diagnosiscancer sitecancer therapycancer typechemotherapychronic depressionchronic paincohortcomparison groupcostfollow-upfundamental researchhealth recordlifestyle factorsmalignant breast neoplasmmeetingsneoplasm registryneurotoxicitypopulation basedpublic health relevance
中文摘要
描述(申请人提供):子宫内膜癌是美国女性癌症幸存者中第二常见的癌症。据估计,目前有60万名子宫内膜癌幸存者。此外,每年还诊断出49,560例子宫内膜癌病例。子宫内膜癌已被NCI确定为研究不足的肿瘤部位,对子宫内膜癌患者的远期效应研究非常有限。由于化疗和放射治疗的毒副作用,癌症患者的晚期反应令人担忧。令人担忧的具体后遗症包括第二原发癌、骨质疏松症、心脏毒性、神经毒性、认知缺陷、抑郁、慢性疲劳、慢性疼痛、不孕不育和性功能障碍。犹他州人口数据库(UPDB)为流行病学研究提供了独特而出色的资源,并将犹他州癌症登记处、医院电子医疗记录、联邦医疗保险、驾驶执照、选民登记、家族历史记录和出生证明的数据联系起来。我们用相同的研究设计成功地完成了对1,001名睾丸癌患者的远期效应研究(93.2%的患者通过EMR获得了成功的随访)。在UPDB与犹他州癌症登记中心的关联数据中,我们建议构建一个覆盖犹他州的基于人群的子宫内膜癌患者队列。我们的具体目标是:(1)汇集3,400名子宫内膜癌患者和17,000名年龄匹配的非癌症女性作为对照组,以人群为基础,调查子宫内膜癌治疗对长期健康影响的发生率;(2)评估使用问卷评估生活方式的可行性
(3)通过对子宫内膜癌患者(n=200)进行病历提取,确定从病历中收集化疗药物等详细癌症治疗信息的可行性;(4)比较从现有记录中获得的信息的质量,以及从问卷中获得的关于晚期效应、合并症和癌症治疗的自我报告(n=1,000)。目标1的后遗症分析是基于现有的数据(癌症登记和EMR的联系),我们能够获得犹他州90%癌症患者的后遗症信息。我们的项目解决了NCI强调的优先研究领域:晚期效应评估,对患有合并症的幸存者的研究,以及专注于未被充分研究的癌症。我们将召集一个史无前例的高质量的基于人群的3,400名子宫内膜癌患者队列,首次研究晚期效应,由于TE UPDB内现有的链接数据库,成本非常低。这一应用也将为未来大规模的基于人群的子宫内膜癌生存项目奠定重要的基础工作。对于60万名子宫内膜癌幸存者和今年将被诊断为癌症的49560名妇女来说,了解癌症治疗的长期影响及其决定因素将非常有价值。
英文摘要
DESCRIPTION (provided by applicant): Endometrial cancer is the second most common cancer among female cancer survivors in the United States. There are an estimated 600,000 endometrial cancer survivors today. Additionally, 49,560 incident endometrial cancer cases are diagnosed each year. Endometrial cancer has been identified by the NCI as an understudied cancer site and late effects research on endometrial cancer patients is very limited to our knowledge. Late effects are of concern among cancer patients due to the toxic effects of chemotherapy and radiotherapy. Specific late effects of concern include second primary cancers, osteoporosis, cardio-toxicity, neuro-toxicity, cognitive deficits, depression, chronic fatigue, chronic pain, infertility and sexual dysfunction. The Utah Population Database (UPDB) provides a unique and excellent resource for epidemiologic research, and links data from the Utah Cancer Registry, hospital electronic medical records, Medicare, driver licenses, voter registration, family history records, and birth certificates. We have successfully completed a study of late effects of 1,001 testicular cancer patients with the same study design (93.2% successfully followed up through the EMR). Within the UPDB linked data with the Utah Cancer Registry, we propose to construct a population- based endometrial cancer patient cohort covering the state of Utah. Our specific aims are: (1) To assemble a population-based cohort of 3,400 endometrial cancer patients and 17,000 age-matched cancer-free women for a comparison group, to investigate the incidence of long-term health effects due to endometrial cancer treatment, (2) To assess the feasibility of administering questionnaires to assess lifestyle
factors in a sample of the endometrial cancer survivors (n=500) and cancer-free women for a comparison group (n=500), (3) To determine the feasibility of collecting detailed cancer treatment information such as chemotherapy agents from medical records by conducting medical record abstraction among a sample of endometrial cancer patients (n=200), (4) To compare the quality of information obtained from the existing records and the self-report from the questionnaire on late effects, comorbidities, and cancer treatment (n=1,000). The aim 1 late effects analysis is based on existing data (linkage of cancer registry and EMR) and we are able to obtain late effects information on >90% of cancer patients in Utah. Our project addresses the priority research areas highlighted by the NCI: assessment of late effects, study of survivors with comorbidities, and focusing on an understudied cancer. We will assemble an unprecedented high-quality population-based cohort of 3,400 endometrial cancer patients to study late effects for the first time, at a very low cost due to existing linked databases within te UPDB. This application will also lay important foundation work for a future large-scale population-based endometrial cancer survivorship project. Understanding the long-term effects of cancer treatment and their determinants will be extremely valuable for the 600,000 endometrial cancer survivors and the 49,560 women who will be diagnosed this year.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry
-
批准号:10673736
-
项目类别:
-
资助金额:$63.97万
-
财政年份:2022
-
负责人:MIA HASHIBE
-
依托单位:
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry
-
批准号:10522203
-
项目类别:
-
资助金额:$67.95万
-
财政年份:2022
-
负责人:MIA HASHIBE
-
依托单位:
Utah Advanced Course on Mentorship and Leadership on Cancer-Related Health Disparities
-
批准号:10368933
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2020
-
负责人:MIA HASHIBE
-
依托单位:
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort
-
批准号:10437842
-
项目类别:
-
资助金额:$47.68万
-
财政年份:2020
-
负责人:MIA HASHIBE
-
依托单位:
Utah Advanced Course on Mentorship and Leadership on Cancer-Related Health Disparities
-
批准号:9905159
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2020
-
负责人:MIA HASHIBE
-
依托单位:
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort
-
批准号:10218125
-
项目类别:
-
资助金额:$48.66万
-
财政年份:2020
-
负责人:MIA HASHIBE
-
依托单位:
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort
-
批准号:10653702
-
项目类别:
-
资助金额:$47.68万
-
财政年份:2020
-
负责人:MIA HASHIBE
-
依托单位:
Utah Advanced Course on Cancer-related Health Disparities Research, Mentoring, & Leadership
-
批准号:10555969
-
项目类别:
-
资助金额:$31.02万
-
财政年份:2020
-
负责人:MIA HASHIBE
-
依托单位:
Improving Our Understanding of Late Oral Health Effects in Head and Neck Cancer Survivors
-
批准号:9768426
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2018
-
负责人:MIA HASHIBE
-
依托单位:
INHANCE Consortium
-
批准号:9328725
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2017
-
负责人:MIA HASHIBE
-
依托单位:
Exome sequencing for head and neck cancer susceptibility genes
-
批准号:8895297
-
项目类别:
-
资助金额:$74.14万
-
财政年份:2014
-
负责人:MIA HASHIBE
-
依托单位:
Exome sequencing for head and neck cancer susceptibility genes
-
批准号:8761870
-
项目类别:
-
资助金额:$73.17万
-
财政年份:2014
-
负责人:MIA HASHIBE
-
依托单位:
Exome sequencing for head and neck cancer susceptibility genes
-
批准号:9107841
-
项目类别:
-
资助金额:$71.42万
-
财政年份:2014
-
负责人:MIA HASHIBE
-
依托单位:
Head and Neck Cancer Risk Prediction Model
-
批准号:8242482
-
项目类别:
-
资助金额:$16.26万
-
财政年份:2012
-
负责人:MIA HASHIBE
-
依托单位:
Head and Neck Cancer Risk Prediction Model
-
批准号:8435387
-
项目类别:
-
资助金额:$18.3万
-
财政年份:2012
-
负责人:MIA HASHIBE
-
依托单位:
Epidemiology of testicular cancer in the Utah population
-
批准号:8114802
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2011
-
负责人:MIA HASHIBE
-
依托单位:
Epidemiology of testicular cancer in the Utah population
-
批准号:8260835
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2011
-
负责人:MIA HASHIBE
-
依托单位:
Pooled Analyses of SNPs and Risk of Head & Neck Cancer
-
批准号:7068606
-
项目类别:
-
资助金额:$11.03万
-
财政年份:2005
-
负责人:MIA HASHIBE
-
依托单位:
Pooled Analyses of SNPs and Risk of Head & Neck Cancer
-
批准号:6904958
-
项目类别:
-
资助金额:$11.3万
-
财政年份:2005
-
负责人:MIA HASHIBE
-
依托单位:
International Head and Neck Cancer Consortium
-
批准号:6889350
-
项目类别:
-
资助金额:$5.87万
-
财政年份:2004
-
负责人:MIA HASHIBE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: